The Nine Mile, S Q217, and Priscilla isolates, representative of the three major genetic groups of Coxiella burnetii, are known to differ in their susceptibilities to antibiotics. Mechanisms potentially responsible for these differences were investigated. Accumulation of antibiotics by infected L929 cells and purified isolates was measured. In addition, C. burnetii plasmid-transformed Escherichia coli HB101 cells were used to study the possibility that different C. 
Recent reports indicate that Coxiella burnetii isolates are genetically distinct and that different isolates may be associated with distinct clinical forms of Q fever-acute versus chronic (13, 23) . Furthermore, the Nine Mile (NM; RSA 493) and Priscilla (PRS; Q177) isolates, implicated in acute and chronic disease syndromes, respectively, exhibit dramatically different susceptibilities to a variety of antibiotics, including doxycycline, rifampin, and several fluoroquinolones (31, 32) . These observations correlate with clinical success in treating acute Q fever and the poor antibiotic manageability of chronically diseased patients (29) . Increased optimism for a more effective treatment of the chronic disease syndrome has been generated by the recent report (34) that ciprofloxacin, a fluoroquinolone antibiotic, has been effective in controlling human chronic Q-fever endocarditis. Other workers have recently reported the failure of this drug to sterilize heart valves (20) . Previously, other investigators (26) demonstrated tetracycline resistance in one C. burnetii isolate (Cyprus). Obligate intracellular pathogens like C. burnetii present special problems in antibiotic resistance: unless drugs can penetrate into phagocytic cells and accumulate in active forms within phagolysosomes, they will be ineffective against such organisms.
The antibiotic susceptibility of C. burnetii isolates, however, is probably not the only factor determining success in patient treatment. In contrast to clinical results, the S Q217 isolate exhibits unexpectedly high antibiotic susceptibilities in vitro (31) . Such results suggest that a patient predisposition factor is partly involved in the development of the chronic disease syndrome.
The drugs to which the three C. burnetii isolates studied (NM, S Q217, and PRS) exhibited differential susceptibilities (30) (31) (32) (33) have different targets and modes of action (19) . It is therefore unlikely that drug-specific mutational alterations account for the differential susceptibilities of the isolates to doxycycline, rifampin, or the fluoroquinolones. Rather, a more broad resistance mechanism, such as decreased permeability or increased efflux of drugs, likely underlies the variability in antibiotic susceptibility observed among the isolates. The possibility that growth rate variation accounts for differences in antibiotic susceptibility has not been ruled out.
In this report, we present results of experiments designed to investigate mechanisms that may account for differential antibiotic susceptibilities observed among C. burnetii isolates. In addition, experiments were performed to examine the possibility that C. burnetii plasmids mediate differential antibiotic susceptibilities. Evidence is presented that indicates that permeability differences among infected host cells and/or the isolates themselves underlie these differences. Furthermore, C. burnetii plasmids do not appear to be directly involved in determining antibiotic susceptibility.
MATERIALS AND METHODS
Source and in vitro propagation of C. burnetii isolates. The phase I C. burnetii NM isolate was obtained from M. Peacock of the Rocky Mountain Laboratory, Hamilton, Mont. The S Q217 and PRS isolates were provided by L. Mallavia, Washington State University, Pullman. All organisms were obtained in yolk sac homogenates and propagated within L929 mouse fibroblast cell cultures (21) . Recent infections were initiated and maintained as described previously (32) Norfloxacin accumulation by purified C. burnetii isolates was also determined by spectrofluorometry with the methods of Chapman and Georgopapadakou (5). Purified C.
burnetii isolates were exposed to norfloxacin (5 pug/ml) in Antibiotic disk diffusion assays of E. coli transductants.
Antibiotic susceptibilities of E. coli HB101 transductants with or without C. burnetii plasmids were determined by using Kirby-Bauer-type disk diffusion assays (3). Ultrapure paper filter disks (12.7 mm; Schleicher & Schuell, Inc., Keene, N.H.) were impregnated with antibiotics and placed on LB-kanamycin agar plates confluently inoculated with E.
coli transductants before incubation (24 h, 37°C). Zones of inhibition of the three transductant strains (pHK17 control, pHK17::QpHl, and pHK17::QpRS) were then compared. This method of assay was also used to determine the susceptibilities of E. coli transductants treated with ciprofloxacin to deplete C. burnetii plasmids (see below). Ciprofloxacin-induced plasmid depletion of E. coli transductants. The methods used in determining the presence of plasmids in E. coli transductants were similar to those used by Weisser and Wiedemann (27) and others (17, 18) . E. coli antibiotic susceptibilities were determined before and after C. burnetii plasmid depletion to establish the role of the plasmids in effecting drug susceptibility. E. coli transductants grown in LB-kanamycin broth (37°C for 24 h, 200 rpm) with or without 0.006 pug of ciprofloxacin per ml were serially diluted and plated on LB agar with or without kanamycin (50 ,ug/ml). Colonies were enumerated after incubation (24 h, 37°C Fig. 1 and 2 ). L929 cells persistently infected with the NM isolate exhibited a significantly higher level of [3H]tetracycline accumulation than did cells infected with either the S Q217 or PRS isolate (Fig. 1) . Furthermore, L929 cells recently infected (22 days) with these isolates accumulated more [3H]tetracycline than did their persistently infected (>100 days) counterparts after 60 min of incubation (Fig. 3) . In contrast, L929 cells infected with the different C. burnetii isolates exhibited no significant difference in their accumulation of [3H]norfloxacin (Fig. 2) . In addition, recent or persistent infection had no detectable effect on L929 cell [3H]norfloxacin accumulation (data not shown).
Antibiotic accumulation studies of purified C. burnetii isolates. NM, S Q217, and PRS isolates of C. burnetii were purified from persistently infected L929 cells and tested for their accumulation of [3H]tetracycline or [3H]norfloxacin at pH 4.5 and 7.5. C. burnetii has been shown to be metabolically active at acidic pH but inactive at neutral pH (11) . Moreover, C. burnetii is known to reside and proliferate within acidic phagolysosomes (2). The three isolates accumulated similar levels of radioactive tetracycline at both pH 4.5 and 7.5 ( Fig. 4 and 5) . However, the PRS isolate accumulated significantly less [3H]norfloxacin than did either the NM or S Q217 isolate ( Fig. 6 and 7) at either pH 4.5 or 7.5; spectrofluorometric norfloxacin accumulation assays confirmed these findings ( Fig. 8 and 9 ). Antibiotic disk diffusion assays of E. coli transductants. Kirby-Bauer-type antibiotic disk diffusion assays (3) were Isolates were purified from L929 fibroblasts persistently infected for over 250 days and brought to equivalent concentrations in modified P-25 buffer (11) . Linear regression analyses were performed on data from three independent experiments with similar results; the linear correlation coefficient was >0.5 (two-tailed test; P < 0.03). QpRS (PRS) plasmids confer antibiotic resistance to the E. coli HB101 transductants (Table 2) .
with a variety of antibiotics, including several quinolones, tetracyclines, aminoglycosides, rifampin, chloramphenicol, nalidixic acid, and several drug combinations. These drugs have been previously shown to possess differential efficacies against the NM, S Q217, and PRS isolates (30) (31) (32) . The antibiotic susceptibilities of C. burnetii plasmid-transduced E. coli HB101 isolates were also determined for transductants treated with ciprofloxacin to eliminate plasmids (Table  1) Isolates were purified from L929 fibroblasts persistently infected for over 250 days and brought to equivalent concentrations in modified P-25 buffer (11) . Linear regression analyses were performed on data from three independent experiments with similar results; the linear correlation coefficient was >0.5 (two-tailed test; P < 0.05).
DISCUSSION
Distinct isolates of C. burnetii have been shown to exhibit significant differences in antibiotic susceptibility in vitro (30) (31) (32) and may be responsible for the distinct clinical disease syndromes of Q fever observed in vivo (13, 23) . The broad in vitro antibiotic resistance characteristic of the PRS isolate, implicated in chronic Q fever, correlates with the poor results in treating chronically infected patients with antibiotics (29) . Recent evidence indicates that, as predicted by in vitro studies (29) (30) (31) (32) , fluoroquinolone antibiotic therapy may be effective in treating chronic Q-fever endocarditis (33). Unexpectedly, the S Q217 C. burnetii isolate, recovered from a chronic Q-fever endocarditis patient for whom long-term antibiotic therapy was ineffective, exhibited much greater susceptibilities to antibiotics in vitro than did the PRS isolate (30) . The patient from whom the S Q217 isolate was recovered had undergone combination rifampin and doxycycline therapy for many months apparently without cure; relapse occurred after cessation of drug treatment (30) . This implies that other factors, including immunological, are involved in the establishment and maintenance of the chronic Q-fever disease syndrome. The NM and PRS isolates possess distinct plasmids (13, 22, 23) ; the S Q217 isolate lacks free plasmid DNA (although it contains plasmid DNA integrated into the chromosome (1, 4, 7, 10, 16) . In our studies, we found that L929 mouse fibroblasts persistently infected with different isolates of C. burnetii differentially accumulated [3H]tetracycline (Fig. 1) . Cells infected with the NM isolate, the most susceptible to tetracycline antibiotics (30) (31) (32) , accumulated significantly more tetracycline than did cells infected with the S or PRS isolate. It is possible that NM C. burnetii infection may result in host cell membrane modification affecting drug uptake. This trend was also observed in L929 cells recently infected with these isolates. Effects of pH on antibiotic accumulation may be important, since C. burnetii proliferates within acid phagolysosomes (2) and has been shown to be metabolically active at pH 4.5 but inactive at pH 7.5 (11). However, in our studies, the C. burnetii isolates themselves, purified from infected L929 cells, did not show differential [3H]tetracycline accumulation at either pH 4.5 or 7.5 ( Fig. 4  and 5) . Collectively, these results suggest that C. burnetii isolates that demonstrate decreased susceptibility to tetracycline-class antibiotics may rely upon or perhaps exploit a host cell permeability barrier to avoid exposure to effective concentrations of these drugs. These results lend support to our previous observations that the NM isolate is much more susceptible to tetracycline-class antibiotics than is either the S Q217 (30) or the PRS (32) isolate. These data also agree with the previous findings that all C. burnetii isolates are more susceptible to antibiotics during recent infection than when involved in long-term persistent infection (30, 32) . From these experiments, it appears that the host cell serves as a barrier to tetracyclines for S and PRS C. burnetii isolates; whether this phenomenon is mediated by these isolates is not known.
Bacterial resistance to the quinolone-naphthyridine group of antibiotics has been shown to be a result of decreased accumulation and increased active efflux or alteration of the DNA gyrase ox-subunit target (5, 12, 25 (Fig. 2) . However, the different C. burnetii isolates did exhibit differential norfloxacin accumulation (Fig. 6 through  9) ; the accumulation pattern observed correlates with isolate susceptibility to the fluoroquinolones (NM > S Q217 >> PRS [30] [31] [32] ). These results suggest that isolate, not host cell, permeability accounts for the differential fluoroquinolone susceptibilities of these organisms.
In an attempt to discern whether C. burnetii QpH1 and QpRS plasmids are involved in antibiotic resistance, we employed E. coli HB101 cells transduced with these plasmids to determine whether their presence altered antibiotic susceptibility. Mallavia and Samuel (13) have previously shown that C. burnetii plasmids are efficiently expressed in E. coli HB101 transductants. Kirby-Bauer-type disk diffusion assays were used in these determinations (3). When exposed to a variety of antibiotics, including several drug combinations, the pHK17::QpH1 (NM) and pHK17::QpRS (PRS) E. coli transductants exhibited nearly identical antibiotic susceptibilities (Table 2) , which were equivalent to those of the pHK17-transduced E. coli HB101 organism that lacked a C. burnetii plasmid (control). These results indicate that, as expressed in E. coli, neither the QpH1 nor QpRS C. burnetii plasmid mediates antibiotic resistance directly. For the quinolones, at least, this conclusion is reasonable in light of the fact that plasmids have not been shown to mediate resistance to these drugs (6, 25) .
The NM, S Q217, and PRS isolates of C. burnetii possess distinct plasmids (13, 22) , have very different antibiotic susceptibilities (30, 32) , and are suspected to cause different clinical syndromes of Q fever (23) . As obligate intracellular parasites, these organisms present unique problems concerning their control with antibiotics; effective drugs must be able to penetrate into and accumulate within infected-cell acidic phagolysosomes in active forms (14) . Collectively, our observations suggest that differential susceptibilities of the C. burnetii isolates to antibiotics are a result of at least two independent mechanisms: differential infected host cell permeability to the tetracycline-class drugs (NM > S Q217 or PRS) and dissimilar permeabilities of the isolates themselves to fluoroquinolone antibiotics (PRS<< NM or S Q217). The mechanism responsible for resistance to rifampin observed in the PRS isolate (32) is unknown. No correlation between C. burnetii plasmid type and antibiotic susceptibility was found. The conclusion that C. burnetii plasmids are not responsible for differences in antibiotic susceptibilities between the NM and PRS isolates is reasonable in light of the broad differences in antibiotic susceptibilities exhibited by the PRS isolate (32) .
The results of these studies indicate that the mechanisms responsible for differential antibiotic susceptibilities among the NM, S Q217, and PRS C. burnetii isolates are based, at least in part, on permeabilities of the cells to antibiotics.
Host cell permeability appears to be involved in C. burnetii isolate susceptibility to tetracycline-class antibiotics; the impermeability of the PRS isolate to fluoroquinolones correlates with its resistance to these antibiotics (32) . It is clear that much more information concerning the biological characteristics of each C. burnetii isolate, as well as the possible roles of their plasmids in pathogenesis, is needed to further understand diversity among C. burnetii isolates.
